Other concurrent condition(s)-Hyperlipidemia Posts on Medivizor
Navigation Menu

Other concurrent condition(s)-Hyperlipidemia Posts on Medivizor

Is a fixed-dose combination of candesartan and rosuvastatin effective at managing hypertension and high cholesterol?

Posted by on Jul 31, 2019 in Hypertension | 0 comments

In a nutshell This study investigated if a combination of candesartan (Atacand) and rosuvastatin (Crestor) is effective in treating hypertension and high blood cholesterol.  They found that this combination was effective in these patients.  Some background Hypertension or high blood pressure (BP) is common...

Read More

Cholesterol-lowering agents and patient outcomes: a review of responses in patients over the age of 65

Posted by on Apr 19, 2019 in Coronary artery disease | 0 comments

In a nutshell This study investigated the effectiveness of cholesterol-lowering agents on cardiovascular outcomes in patients aged over 65. They found that statins reduced the risk of cardiovascular events including heart attack and death. Some background Coronary artery disease (CAD) is caused by blockages in the arteries supplying blood to...

Read More

Evaluating an implantable device for early recognition of a heart attack

Posted by on Apr 5, 2019 in Coronary artery disease | 0 comments

In a nutshell The aim of this study was to examine how effective a new implantable device is in recognizing and alerting patients that they are having a heart attack. The main finding of the study was that the device successfully detected heart attacks and alerted patients of a potential blockage of their blood vessels. Some background Heart disease...

Read More

Searching for patients with coronary artery disease to test a new medication

Posted by on Jan 27, 2019 in Coronary artery disease | 0 comments

In a nutshell This phase 3 trial will determine if bempedoic acid (BPDA) reduces the risk of cardiovascular events (CVEs) in statin-intolerant (ST-IT) patients. The main outcome will be the time taken for a CVE to occur. The details Cardiovascular disease (CVD) is a serious condition that can lead to serious events (CVEs). CVEs include heart...

Read More

Will an intensive statin treatment change composition of plaque?

Posted by on Jul 25, 2015 in Coronary artery disease | 0 comments

In a nutshell This paper studied the effect of an early intensive statin treatment in patients who have had a heart attack. Some background Plaque occurs when fat (cholesterol, for example) and other types of cells (calcium, for example) build up into a waxy substance in the blood vessels. When these plaques rupture, they can obstruct the blood...

Read More

Comparison between high versus moderate or low doses of statins in preventing cardiovascular events

Posted by on Jul 13, 2013 in Coronary artery disease | 0 comments

In a nutshell This study investigated whether higher doses of statins significantly improved cardiovascular outcomes compared to moderate or low doses. Some background Statins are a group of drugs used to lower cholesterol levels in the body. They notably reduce LDL-cholesterol levels, commonly referred to as the "bad" cholesterol....

Read More

Blood pressure targets in high risk patients

Posted by on Jul 8, 2013 in Hypertension | 0 comments

In a nutshell In this article, the latest clinical trials are reviewed in an attempt to conclude what is the optimal blood pressure target for patients of cardiovascular (CV) events, such as heart attack or stroke. Some background Hypertension is defined as blood pressure higher than 140/90 mmHg at rest. The higher value is called systolic (SBP),...

Read More

A healthy diet reduces the risk of complications in patients medicated for cardiovascular disease or diabetes

Posted by on Jun 20, 2013 in Coronary artery disease | 0 comments

In a nutshell The present study examined whether combining a healthy diet with medications has an added benefit on the risk of cardiovascular events, such as heart attacks and strokes . Some background Cardiovascular diseases (CVD) are conditions affecting the heart and/or blood vessels. Many medications, such as beta blockers,...

Read More

Two classes of drugs that reduce the likelihood of cardiovascular complications in patients at high risk of heart failure

Posted by on Jun 13, 2013 in Coronary artery disease | 0 comments

In a nutshell The present study evaluated the effect of two drug groups – Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – on cardiovascular (CV)-related events (e.g. heart attacks, strokes), occurence of heart failure (HF) and death, in patients with normal heart...

Read More